| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The FASEB Journal, Vol 6, 3387-3396, Copyright © 1992 by The Federation of American Societies for Experimental Biology
REVIEWS |
T Taga and T Kishimoto
Division of Immunology, Osaka University, Japan.
Most of the recently cloned cytokine receptors that operate in the immune and hematopoietic systems contain no tyrosine kinase domains in their cytoplasmic regions, unlike the family of growth factor receptors defined earlier. However, they can be assigned to several new types of receptor families based on structural similarities among them. It is characteristic of these receptors that many of them require a receptor- associated molecule in order to achieve high-affinity ligand binding and/or transmission of cytoplasmic signals. Receptor-associated molecules have been found that transduce cytoplasmic signals and are shared by different cytokine receptors. Phosphorylation of the receptors and of various cytoplasmic proteins after ligand stimulation seems to be a common event in cytokine systems. Insight into the pleiotropic and redundant nature of cytokine action is provided by the discovery of several new cytokine receptor families and of shared signal transduction molecules and by the idea that several cytoplasmic kinases may be able to functionally substitute for one another in transmitting cytokine signals.
This article has been cited by other articles:
|
|
 |
|
  A. J. Lickteig, A. L. Slitt, M. C. Arkan, M. Karin, and N. J. Cherrington Differential Regulation of Hepatic Transporters in the Absence of Tumor Necrosis Factor-{alpha}, Interleukin-1{beta}, Interleukin-6, and Nuclear Factor-{kappa}B in Two Models of Cholestasis Drug Metab. Dispos., March 1, 2007; 35(3): 402 - 409. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. L. Stoll, G. M. Denning, and N. L. Weintraub Potential Role of Endotoxin as a Proinflammatory Mediator of Atherosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2004; 24(12): 2227 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ducret, A.-M. Vacher, and P. Vacher Effects of Prolactin on Ionic Membrane Conductances in the Human Malignant Astrocytoma Cell Line U87-MG J Neurophysiol, March 1, 2004; 91(3): 1203 - 1216. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Underhill-Day, L. A. McGovern, N. Karpovich, H. J. Mardon, V. A. Barton, and J. K. Heath Functional Characterization of W147A: A High-Affinity Interleukin-11 Antagonist Endocrinology, August 1, 2003; 144(8): 3406 - 3414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M Roth and L H Block Distinct effects of Broncho-Vaxom (OM-85 BV) on gp130 binding cytokines Thorax, August 1, 2000; 55(8): 678 - 684. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Stephanou, B. K. Brar, T. M. Scarabelli, A. K. Jonassen, D. M. Yellon, M. S. Marber, R. A. Knight, and D. S. Latchman Ischemia-induced STAT-1 Expression and Activation Play a Critical Role in Cardiomyocyte Apoptosis J. Biol. Chem., March 31, 2000; 275(14): 10002 - 10008. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. G. Tidball, M. J. Spencer, M. Wehling, and E. Lavergne Nitric-oxide Synthase Is a Mechanical Signal Transducer That Modulates Talin and Vinculin Expression J. Biol. Chem., November 12, 1999; 274(46): 33155 - 33160. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. W. Nadeau, P. Domanski, A. Usacheva, S. Uddin, L. C. Platanias, P. Pitha, R. Raz, D. Levy, B. Majchrzak, E. Fish, et al. The Proximal Tyrosines of the Cytoplasmic Domain of the beta Chain of the Type I Interferon Receptor Are Essential for Signal Transducer and Activator of Transcription (Stat) 2 Activation. EVIDENCE THAT TWO Stat2 SITES ARE REQUIRED TO REACH A THRESHOLD OF INTERFERON alpha -INDUCED Stat2 TYROSINE PHOSPHORYLATION THAT ALLOWS NORMAL FORMATION OF INTERFERON-STIMULATED GENE FACTOR 3 J. Biol. Chem., February 12, 1999; 274(7): 4045 - 4052. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang and S. Melmed Functional Map of a Placenta-specific Enhancer of the Human Leukemia Inhibitory Factor Receptor Gene J. Biol. Chem., October 2, 1998; 273(40): 26069 - 26077. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Bole-Feysot, V. Goffin, M. Edery, N. Binart, and P. A. Kelly Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice Endocr. Rev., June 1, 1998; 19(3): 225 - 268. [Abstract] [Full Text]
|
|
|
|
|
|
L. C. Platanias, P. Domanski, O. W. Nadeau, T. Yi, S. Uddin, E. Fish, B. G. Neel, and O. R. Colamonici Identification of a Domain in the beta Subunit of the Type I Interferon (IFN) Receptor That Exhibits a Negative Regulatory Effect in the Growth Inhibitory Action of Type I IFNs J. Biol. Chem., March 6, 1998; 273(10): 5577 - 5581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Domanski, O. W. Nadeau, L. C. Platanias, E. Fish, M. Kellum, P. Pitha, and O. R. Colamonici Differential Use of the beta L Subunit of the Type I Interferon (IFN) Receptor Determines Signaling Specificity for IFNalpha 2 and IFNbeta J. Biol. Chem., February 6, 1998; 273(6): 3144 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Wang and S. Melmed Identification of an Upstream Enhancer within a Functional Promoter of the Human Leukemia Inhibitory Factor Receptor Gene and Its Alternative Promoter Usage J. Biol. Chem., October 31, 1997; 272(44): 27957 - 27965. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kumanogoh, S. Marukawa, T. Kumanogoh, H. Hirota, K. Yoshida, I.-S. Lee, T. Yasui, K. Yoshida, T. Taga, and T. Kishimoto Impairment of antigen-specific antibody production in transgenic mice expressing a dominant-negative form of gp130 PNAS, March 18, 1997; 94(6): 2478 - 2482. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. Davidson, S.-A. Freeman, K. E. Crosier, C. R. Wood, and P. S. Crosier Expression of Murine Interleukin 11 and its Receptor {alpha}-Chain in Adult and Embryonic Tissues Stem Cells, March 1, 1997; 15(2): 119 - 124. [Abstract] [Full Text]
|
|
|
|
|
|
C. Gerhartz, B. Heesel, J. Sasse, U. Hemmann, C. Landgraf, J. Schneider-Mergener, F. Horn, P. C. Heinrich, and L. Graeve Differential Activation of Acute Phase Response Factor/STAT3 and STAT1 via the Cytoplasmic Domain of the Interleukin 6 Signal Transducer gp130. I. DEFINITION OF A NOVEL PHOSPHOTYROSINE MOTIF MEDIATING STAT1 ACTIVATION J. Biol. Chem., May 31, 1996; 271(22): 12991 - 12998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zhang, M. Sun, D. Samols, and I. Kushner STAT3 Participates in Transcriptional Activation of the C-reactive Protein Gene by Interleukin-6 J. Biol. Chem., April 19, 1996; 271(16): 9503 - 9509. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. H. Régnier, C. Tomasetto, C. Moog-Lutz, M.-P. Chenard, C. Wendling, P. Basset, and M.-C. Rio Presence of a New Conserved Domain in CART1, a Novel Member of the Tumor Necrosis Factor Receptor-associated Protein Family, Which Is Expressed in Breast Carcinoma J. Biol. Chem., October 27, 1995; 270(43): 25715 - 25721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pennica, K. J. Shaw, T. A. Swanson, M. W. Moore, D. L. Shelton, K. A. Zioncheck, A. Rosenthal, T. Taga, N. F. Paoni, and W. I. Wood Cardiotrophin-1 J. Biol. Chem., May 5, 1995; 270(18): 10915 - 10922. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
